Therapeutic potential of plant iridoids in depression: a review.
Therapeutic potential of plant iridoids in depression: a review.
复制标题
DOI:
10.1080/13880209.2022.2136206
复制
发表时间:
2022-12
影响因子:
3.8
通讯作者:
Zhao, Ye
中科院分区:
文献类型:
--
作者:
Kou, Yaoyao;Li, Zhihao;Yang, Tong;Shen, Xue;Wang, Xin;Li, Haopeng;Zhou, Kun;Li, Luyao;Xia, Zhaodi;Zheng, Xiaohui;Zhao, Ye
Depression is a mental disorder characterized by low mood, reduced interest, impaired cognitive function, and vegetative symptoms such as sleep disturbances or poor appetite. Iridoids are the active constituents in several Chinese classical antidepressant formulae such as Yueju Pill, Zhi-Zi-Hou-Po Decoction, Zhi-Zi-Chi Decoction, and Baihe Dihuang Decoction. Parallel to their wide usages, iridoids are considered potential lead compounds for the treatment of neurological diseases. The review summarizes the therapeutic potential and molecular mechanisms of iridoids in the prevention or treatment of depression and contributes to identifying research gaps in iridoids as potential antidepressant medication. The following key phrases were sought in PubMed, Google Scholar, Web of Science, and China National Knowledge Internet (CNKI) without time limitation to search all relevant articles with in vivo or in vitro experimental studies as comprehensively as possible: (‘iridoid’ or ‘seciridoid’ or ‘depression’). This review extracted the experimental data on the therapeutic potential and molecular mechanism of plant-derived iridoids for depression. Plant iridoids (i.e., catalpol, geniposide, loganin), and secoiridoids (i.e., morroniside, gentiopicroside, oleuropein, swertiamarin), all showed significant improvement effects on depression. Iridoids exert antidepressant effects by elevating monoamine neurotransmitters, reducing pro-inflammatory factors, inhibiting hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, increasing brain-derived neurotrophic factor (BDNF) and its receptors, and elevating intestinal microbial abundance. Further detailed studies on the pharmacokinetics, bioavailability, and key molecular targets of iridoids are also required in future research, ultimately to provide improvements to current antidepressant medications.
登录
查看更多内容
DOI:
10.1177/2470547020971232
发表时间:
2021-01
期刊:
Chronic stress (Thousand Oaks, Calif.)
影响因子:
--
作者:
Varghese SP;Florentin OD;Koola MM
通讯作者:
Koola MM
影响因子:
7.2
作者:
Chen, Tong;Liu, Shengnan;He, Ling
通讯作者:
He, Ling
影响因子:
1.7
作者:
ANDERSEN, H;BRAESTRUP, C;RANDRUP, A
通讯作者:
RANDRUP, A
影响因子:
2.7
作者:
Choi, Ra-Yeong;Nam, Sang-Jip;Lee, Mi-Kyung
通讯作者:
Lee, Mi-Kyung
DOI:
10.1016/s0140-6736(17)32802-7
发表时间:
2018-04-07
期刊:
Lancet (London, England)
影响因子:
--
作者:
Cipriani A;Furukawa TA;Salanti G;Chaimani A;Atkinson LZ;Ogawa Y;Leucht S;Ruhe HG;Turner EH;Higgins JPT;Egger M;Takeshima N;Hayasaka Y;Imai H;Shinohara K;Tajika A;Ioannidis JPA;Geddes JR
通讯作者:
Geddes JR